Bank of Nova Scotia Has $684,000 Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Bank of Nova Scotia cut its position in HealthEquity, Inc. (NASDAQ:HQYGet Rating) by 11.9% during the second quarter, Holdings Channel.com reports. The institutional investor owned 11,142 shares of the company’s stock after selling 1,512 shares during the quarter. Bank of Nova Scotia’s holdings in HealthEquity were worth $684,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. BlackRock Inc. raised its stake in shares of HealthEquity by 4.0% in the first quarter. BlackRock Inc. now owns 9,423,008 shares of the company’s stock worth $635,488,000 after acquiring an additional 358,743 shares during the last quarter. Wasatch Advisors Inc. raised its stake in shares of HealthEquity by 3.3% in the first quarter. Wasatch Advisors Inc. now owns 7,638,935 shares of the company’s stock worth $515,170,000 after acquiring an additional 244,868 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of HealthEquity by 3.2% in the first quarter. JPMorgan Chase & Co. now owns 2,669,705 shares of the company’s stock worth $180,045,000 after acquiring an additional 81,859 shares during the last quarter. State Street Corp raised its stake in shares of HealthEquity by 2.6% in the first quarter. State Street Corp now owns 2,642,658 shares of the company’s stock worth $178,221,000 after acquiring an additional 68,071 shares during the last quarter. Finally, Brown Advisory Inc. raised its stake in shares of HealthEquity by 2.9% in the first quarter. Brown Advisory Inc. now owns 1,757,684 shares of the company’s stock worth $118,304,000 after acquiring an additional 49,054 shares during the last quarter. 99.43% of the stock is owned by institutional investors.

Insider Activity

In other news, EVP Delano Ladd sold 5,897 shares of the company’s stock in a transaction that occurred on Friday, October 21st. The shares were sold at an average price of $75.00, for a total value of $442,275.00. Following the completion of the transaction, the executive vice president now owns 37,471 shares in the company, valued at $2,810,325. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Debra Charlotte Mccowan sold 4,225 shares of the stock in a transaction on Tuesday, September 27th. The shares were sold at an average price of $70.91, for a total transaction of $299,594.75. Following the completion of the transaction, the director now owns 7,072 shares in the company, valued at $501,475.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Delano Ladd sold 5,897 shares of the stock in a transaction on Friday, October 21st. The stock was sold at an average price of $75.00, for a total transaction of $442,275.00. Following the transaction, the executive vice president now owns 37,471 shares of the company’s stock, valued at approximately $2,810,325. The disclosure for this sale can be found here. Insiders sold 46,648 shares of company stock worth $3,355,690 over the last quarter. 2.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

HQY has been the subject of a number of research analyst reports. Jefferies Financial Group boosted their target price on shares of HealthEquity from $80.00 to $90.00 in a research note on Wednesday, November 2nd. Wells Fargo & Company boosted their price target on shares of HealthEquity from $100.00 to $104.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 25th. StockNews.com raised shares of HealthEquity from a “sell” rating to a “hold” rating in a research note on Monday, November 14th. KeyCorp assumed coverage on shares of HealthEquity in a research note on Thursday, September 15th. They set an “overweight” rating and a $85.00 price target for the company. Finally, Raymond James boosted their price target on shares of HealthEquity from $70.00 to $75.00 and gave the stock an “outperform” rating in a research note on Monday, September 12th. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $77.64.

HealthEquity Stock Performance

Shares of NASDAQ:HQY opened at $61.63 on Friday. HealthEquity, Inc. has a 52 week low of $36.81 and a 52 week high of $79.20. The company has a market capitalization of $5.21 billion, a PE ratio of -83.28, a PEG ratio of 3.29 and a beta of 0.87. The company has a 50 day moving average price of $70.76 and a two-hundred day moving average price of $64.86.

HealthEquity (NASDAQ:HQYGet Rating) last released its quarterly earnings results on Tuesday, September 6th. The company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.01). The company had revenue of $206.14 million during the quarter, compared to analyst estimates of $203.40 million. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. During the same quarter last year, the company earned $0.21 EPS. On average, sell-side analysts forecast that HealthEquity, Inc. will post 0.69 earnings per share for the current year.

HealthEquity Profile

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Articles

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYGet Rating).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.